MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients

被引:12
|
作者
Moghoofei, Mohsen [1 ,2 ]
Najafipour, Sohrab [3 ]
Mostafaei, Shayan [1 ,4 ]
Tavakoli, Ahmad [5 ]
Bokharaei-Salim, Farah [5 ]
Ghorbani, Saied [5 ]
Javanmard, Davod [6 ,7 ]
Ghaffari, Hadi [8 ]
Monavari, Seyed Hamidreza [5 ]
机构
[1] Kermanshah Univ Med Sci, Med Biol Res Ctr, Hlth Technol Inst, Kermanshah, Iran
[2] Kermanshah Univ Med Sci, Fac Med, Dept Microbiol, Kermanshah, Iran
[3] Fasa Univ Med Sci, Fac Med, Dept Microbiol, Fasa, Iran
[4] Kermanshah Univ Med Sci, Fac Hlth, Dept Biostat, Kermanshah, Iran
[5] Iran Univ Med Sci, Fac Med, Dept Virol, Tehran, Iran
[6] Birjand Univ Med Sci, Infect Dis Res Ctr, Birjand, Iran
[7] Birjand Univ Med Sci, Fac Med, Dept Med Microbiol, Birjand, Iran
[8] Semnan Univ Med Sci, Sch Med, Dept Bacteriol & Virol, Semnan, Iran
关键词
HIV; HCV; coinfection; microRNA; PBMC; AIDS; BLOOD MONONUCLEAR-CELLS; COMBINATION THERAPY; IRANIAN PATIENTS; GENE-EXPRESSION; VIRUS; RNA; REPLICATION; COINFECTION; DISEASE; GENOME;
D O I
10.2174/1570162X18666200908112113
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections are important public health issues. Objective: This study aimed to assess the association between microRNAs expression leveland immunological and viral markers in HIV, HCV, and HIV/HCV co-infected patients. Methods: The expression level of miR-29, miR-149, miR-199, miR-let7, miR-223, miR-155, miR-122, and miR-150 was evaluated in 20 HIV, 20 HCV, 20 co-infected patients, and 20 healthy controls using real-time PCR assay. HIV and HCVviral loads were measuredby real-time PCR, and also, CD4(+) T-lymphocyte count was measuredby the PIMA CD4 analyzer. Results: The miRNA expression pattern in each mentioned group showed significantly different expression profiles, but some miRNA species were shared between the groups. MiR-122 and miR-155 were upregulated, while miR-29 and miR-223 were downregulated in three patients groups compared to healthy controls. A significant positive correlation was observed between the expression of miR-122 and HIV/HCV loads. But, miR-29 and let-7 were negatively correlated with HIV load, and miR-149 and let-7 were negatively correlated with HIV load. Also, miR-155 was positively correlated with HCV load. MiR-122 and miR-199 were negative while others were positively correlated with CD4+ T cell count. Conclusion: These miRNAs are probably involved in the clinical progression and pathogenesis of HIV and HCV infections. Therefore, determining and manipulating these miRNAs can lead to opening a new gate to control these important infections.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [1] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
    Bollepalli, S
    Mahthieson, K
    Post, J
    Hillier, A
    Nadir, A
    [J]. HEPATOLOGY, 2005, 42 (04) : 423A - 423A
  • [2] Inflammatory cells and apoptosis in HCV and co-infected HCV/HIV patients
    Petrovic, L.
    Rohan, S.
    Hayek, E.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 74 - 74
  • [3] Comparison of therapeutic results on HCV and HCV/HIV co-infected patients
    Serra, J. E.
    Guzman, D.
    Velez, J.
    Pinto, P.
    Marques, N. M.
    da Cunha, J. G. Saraiva
    Melico-Silvestre, A.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S144 - S144
  • [4] Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients
    N. Ciccarelli
    M. Fabbiani
    P. Grima
    K. Falasca
    M. Tana
    E. Baldonero
    M. Colafigli
    M. C. Silveri
    J. Vecchiet
    R. Cauda
    S. Di Giambenedetto
    [J]. Infection, 2013, 41 : 1103 - 1109
  • [5] Sofosbuvir and ledipasvir for HIV/HCV co-infected patients
    Rosenthal, Elana S.
    Kottilil, Shyam
    Polis, Michael A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 743 - 749
  • [6] Survival in HCV/HIV co-infected patients.
    Hassanein, TI
    Aronson, N
    Oliver, DL
    Barber, E
    Hilsabeck, RC
    Chatfield, E
    Stewart, M
    Mathews, C
    [J]. HEPATOLOGY, 2001, 34 (04) : 232A - 232A
  • [7] Metabolic Syndrome in HIV/HCV Co-infected Patients
    Lauren F. Collins
    Ruth O. Adekunle
    Emily J. Cartwright
    [J]. Current Treatment Options in Infectious Diseases, 2019, 11 : 351 - 371
  • [8] Liver fibrosis in HIV/HCV co-infected patients
    Cajoto, IV
    Airas, EL
    Martínez, AP
    Guirao, AA
    [J]. MEDICINA CLINICA, 2005, 124 (12): : 477 - 477
  • [9] Hospital epidemiology of patients co-infected by HIV and HCV
    Thélot, B
    Pialoux, G
    Delhommeau, A
    Piroth, L
    Salmon-Céron, D
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (10): : 605 - 608
  • [10] Metabolic Syndrome in HIV/HCV Co-infected Patients
    Collins, Lauren F.
    Adekunle, Ruth O.
    Cartwright, Emily J.
    [J]. CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (04) : 351 - 371